Poseida Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9390 Towne Centre Dr Ste 200, San Diego,...Phone Number
(858) 779-3100Website
www.poseida.comRevenue
$54.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Poseida Therapeutics
Founded in 2014, Poseida Therapeutics is a biotechnology company that develops and discovers therapies for patients with high unmet medical needs such as blood and tumors cancer. Poseida. Poseida Therapeutics is located in California.Explore more
Poseida Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Poseida Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Poseida Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Poseida Therapeutics
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Poseida Therapeutics launches new products
Poseida Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Poseida Therapeutics is spiking on competitors!
Check if Poseida Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Poseida Therapeutics recently announced quarterly report
Click to see if Poseida Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Poseida Therapeutics
Find 2 more new buyers
Compare Similar Companies to Poseida Therapeutics
Compare insights from companies similar to Poseida Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Poseida Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Poseida Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Poseida Therapeutics.
Poseida Therapeutics financials insights
Gather financial insights about Poseida Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$23M
2017
Private Equity
$11.2M
Unspecified
$19.8M
2018
Series B
$30.5M
2019
Series C
$142M
2020
Series D
$110M
Stock Offering
$204.8M
2023
Share Placement
$25M
Poseida Therapeutics Tech Stack
A closer look at the technologies used by Poseida Therapeutics
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Poseida Therapeutics is considering the purchase of solutions related to community management, content marketing such as NING, AdvisorStream.
Spending/Investment, Content Management, Customer Experience, Customer Retention & Development, Marketing Operations
Award
Employee Engagement, Employee Relations, Company Culture & Policy, HR Operations
Poseida Therapeutics News & Media
Roche to complete acquisition of U.S. biopharma company Poseida
ZURICH (Reuters) -Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics , a specialist in complex immune cell therapies to treat several types of blood cancer. Roche said it has accepted for payment nearly 65 million shares in Poseida - equivalent to 66% of the California company's stock - which had been tendered by shareholders at a price of $9 per share, with an additional contingent paymentRoche purchases shares in tender offer for Poseida Therapeutics, Inc.
Basel, 8 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Blue Giant Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of Poseida Therapeutics, Inc. (“Poseida”, NASDAQ: PSTX) at a price of $9.00 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain contingent payments ofPSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Poseida Therapeutics, Inc. (NASDAQ: PSTX) to Roche Holdings, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right to receive certain contingent payments of up to an aggregate of $4.00 per share in cash upon achievement of specific milestones, is fair to Poseida shareholders. Halper Sadeh encourages Poseida shareholders to click here to learn more aboutRoche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash
Basel, 9 December 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has commenced a tender offer for all of the outstanding shares of common stock of Poseida Therapeutics, Inc. (Poseida) (NASDAQ: PSTX) at a price of $9.00 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain contingent payments of up to an aggregate of $4.00 per share in cash. The tender offer is being made pursuant to
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Poseida Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2014, Poseida Therapeutics is a biotechnology company that develops and discovers therapies for patients with high unmet medical needs such as blood and tumors cancer. Poseida. Poseida Therapeutics is located in California.... Read More
